Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 9/2013

01-09-2013 | Migraine (R Cowan, Section Editor)

Why Does Vomiting Stop a Migraine Attack?

Authors: Nu Cindy Chai, Robert E. Shapiro, Alan M. Rapoport

Published in: Current Pain and Headache Reports | Issue 9/2013

Login to get access

Abstract

Migraine is commonly associated with nausea and vomiting, though, interestingly, vomiting has also been reported by some patients to be therapeutic, and may actually stop a migraine attack. In this review, we will first discuss the epidemiology of nausea and vomiting in migraine. Further, we will briefly review the connections between the enteric nervous system, the autonomic nervous system, and the central nervous system as they pertain to understanding the question of “Why does vomiting stop a migraine attack?”
Literature
1.
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004;24 (Suppl.):S24–101.
2.
Martins IP, Parreira E. Behavioral response to headache: a comparison between migraine and tension-type headache. Headache. 2001;41:546–53.PubMedCrossRef
3.
Bag B, Karabulut N. Pain-relieving factors in migraine and tension-type headache. Int J Clin Pract. 2005;59:760–3.PubMedCrossRef
4.
Young WB, Silberstein SD. Migraine and other headaches. New York: AAN Press, Demos Medical Publishing; 2004.
5.
6.
Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry. 1960;23:23–32.PubMedCrossRef
7.
Lance JW, Anthony M. Some clinical aspects of migraine. A prospective survey of 500 patients. Arch Neurol. 1966;15:356–61.PubMedCrossRef
8.
Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache. 1995;35:387–96.PubMedCrossRef
9.
• Lipton RB, Buse DC, Saiers J, et al. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2012;53:93–103. Persons with high-frequency nausea were found to bear higher burden of migraine, associated with being occupationally disabled and having more financial burden. PubMedCrossRef
10.
Gupta R, Bhatia MS. A report of cranial autonomic symptoms in migraineurs. Cephalalgia. 2007;27:22–8.PubMedCrossRef
11.
Eidlitz-Markus T, Gorali O, Haimi-Cohen Y, et al. Symptoms of migraine in the paediatric population by age group. Cephalalgia. 2008;28:1259–63.PubMedCrossRef
12.
Gershon MD, Chalazonitis A, Rothman TP. From neural crest to bowel: development of the enteric nervous system. J Neurobiol. 1993;24:199–214.PubMedCrossRef
13.
Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453–66.PubMedCrossRef
14.
Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625–32.PubMedCrossRef
15.
Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology. 2007;69:1953–7.PubMedCrossRef
16.
Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261–74.PubMedCrossRef
17.
Becker DE. Nausea, vomiting, and hiccups: a review of mechanism and treatment. Anesthesia Progress. 2010;57:150–6.PubMedCrossRef
18.
Sanger GJ, Andrews PL. Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci. 2006;129:3–16.PubMedCrossRef
19.
Andrews PL, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125:100–15.PubMedCrossRef
20.
• Napadow V, Sheehan JD, Kim J, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex. 2013;23:806–13. Nausea evoked by visual stimuli is mapped with functional magnetic resonance imaging.PubMedCrossRef
21.
Shapiro RE, Miselis RR. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol. 1985;238:473–88.PubMedCrossRef
22.
Travagli RA, Hermann GE, Browning KN, et al. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006;68:279–305.PubMedCrossRef
23.
Hornby PJ. Receptors and transmission in the brain-gut axis. II Excitatory amino acid receptors in the brain-gut axis Am J Physiol Gastrointest Liver Physiol. 2001;280:G1055–60.
24.
Guyton AC, Hall JE. Textbook of medical physiology. 11th ed. Philadelphia, PA: Elsevier; 2006. p. 823–4.
25.
McCarthy LE, Borison HL. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat Rep. 1984;68:401–4.PubMed
26.
Lewis T. Pain. New York: Macmillan; 1942. p. 192.
27.
Troncon LE, Thompson DG, Ahluwalia NK, et al. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut. 1995;37:17–22.PubMedCrossRef
28.
Miller AD, Nonaka S, Jakus J. Brain areas essential or non-essential for emesis. Brain Res. 1994;647:255–64.PubMedCrossRef
29.
Ahn AH, Brennan KC. Unanswered questions in headache: how does a migraine attack stop? Headache. 2012;52:186–7.PubMedCrossRef
30.
31.
Vingen JV, Sand T, Stovner LJ. Sensitivity to various stimuli in primary headaches: a questionnaire study. Headache. 1999;39:552–8.PubMedCrossRef
32.
Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.PubMedCrossRef
33.
Wober C, Brannath W, Schmidt K, et al. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia. 2007;27:304–14.PubMedCrossRef
34.
Aurora SK, Kori SH, Barrodale P, et al. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache. 2006;46:57–63.PubMedCrossRef
35.
Aurora S, Kori S, Barrodale P, Nelsen A, et al. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache. 2007;47:1443–6.PubMedCrossRef
36.
• Aurora SK, Papapetropoulos S, Kori SH, et al. Gastric stasis in migraineurs: Etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33:408–15. A review on the physiologic link between migraine and autonomic dysfunction, specifically gastric stasis. PubMedCrossRef
37.
38.
Hasler WL, Wilson LA, Parkman HP, et al. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil. 2013 Feb 17 [Epub ahead of print].
39.
Eadie MJ. An 18th century understanding of migraine - Samuel Tissot (1728–1797). J Clin Neurosci. 2003;10:414–9.PubMedCrossRef
40.
Parkman HP, Yates K, Hasler WL. et al; National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101–15.PubMedCrossRef
41.
Maniyar FH, Sprenger T, Monteith T, et al. Investigating the premonitory phase of migraine with H2 15O PET. Cephalalgia. 2013;33(8 Suppl):12.
42.
Rinaman L, Card JP, Schwaber JS, Miselis RR. Ultrastructural demonstration of a gastric monosynaptic vagal circuit in the nucleus of the solitary tract in rat. J Neurosci. 1989;9:1985–96.PubMed
43.
Zhang W, Segura BJ, Lin TR, et al. Intercellular calcium waves in cultured enteric glia from neonatal guinea pig. Glia. 2003;42:252–62.PubMedCrossRef
44.
Brennan KC, Bates EA, Shapiro RE, et al. Casein kinase Iδ mutations in familial migraine and advanced sleep phase. Sci Transl Med. 2013;5:(183)ra56.
45.
Lenaerts ME, Oommen KJ, Couch JR, et al. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392–5.PubMedCrossRef
46.
Holtmann G, Goebell H, Jockenhoevel F, et al. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998;42:501–6.PubMedCrossRef
47.
Zhang X, Cao B, Yan N, et al. Vagus nerve stimulation modulates visceral pain-related affective memory. Behav Brain Res. 2013;236:8–15.PubMedCrossRef
48.
Chen SL, Wu XY, Cao ZJ, et al. Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1441–9.PubMedCrossRef
49.
Sadler RM, Purdy RA, Sahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia. 2002;22:482–4.PubMedCrossRef
50.
Hord ED, Evans MS, Mueed S, et al. The effect of vagus nerve stimulation on migraines. J Pain. 2003;4:530–4.PubMedCrossRef
51.
Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–6.PubMedCrossRef
52.
Cecchini AP, Mea E, Tullo V, et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: Preliminary data. Neurol Sci. 2009;30 Suppl 1:S101–4.PubMedCrossRef
53.
Goadsby, et al. Non-invasive vagus nerve stimulation (nVNS) for acute treatment of migraine: an open-label pilot study, presented at the 2013 AAN Meeting, San Diego, CA, 20 March 2013.
54.
Randich A, Gebhart GF. Vagal afferent modulation of nociception. Brain Res Brain Res Rev. 1992;17:77–99.PubMedCrossRef
55.
Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine attacks. Ann Neurol. 1990;28:183–7.PubMedCrossRef
56.
Lassen LH, Haderslev PA, Jacobsen VB, et al. CGRP may play a causative role in migraine. Cephalalgia. 2002;22:54–61.PubMedCrossRef
57.
Ho AP, Dahlof CG, Silberstein SD, et al. Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia. 2010;30:1443–57.PubMedCrossRef
58.
Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine: Current understanding and state of development. Headache. 2013, in press.
59.
Rowe JW, Shelton RL, Helderman JH. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979;16:729–35.PubMedCrossRef
60.
Faull CM, Rooke P, Baylis PH. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man. Clin Endocrinol (Oxf). 1991;35:423–30.PubMedCrossRef
61.
Gupta VK. A clinical review of the adaptive role of vasopressin in migraine. Cephalalgia. 1997;17:561–9.PubMedCrossRef
62.
Berkenbosch F, De Goeij DC, Tilders FJ. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology. 1989;125:28–34.PubMedCrossRef
63.
Gupta VK. Cyclic vomiting syndrome: anticipatory stress response in migraine? Headache. 2004;44:106–7.PubMedCrossRef
64.
Raskind MA, Courtney N, Murburg MM, et al. Antipsychotic drugs and plasma vasopressin in normal and acute schizophrenic patients. Biol Psychiatry. 1987;22:453–62.PubMedCrossRef
65.
Porth CJ, Bamarah VS, Tristani FE, et al. The Valsalva maneuver: mechanisms and clinical implications. Heart Lung. 1984;13:507–18.PubMed
66.
Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: evidence for peripheral sensitization. Lancet Neurol. 2009;8:679–90.PubMedCrossRef
67.
Wolff HG Headache and other head pain. 2nd edn. Oxford: Oxford University Press; 1963.
68.
Iversen HK, Nielsen TH, Olesen J, et al. Arterial responses during migraine headache. Lancet. 1990;336:837–9.PubMedCrossRef
69.
Wienecke T, Olesen J, Ashina M. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2010;30:179–90.PubMed
70.
71.
Drummond PD, Lance JW. Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol. 1983;13:32–7.PubMedCrossRef
72.
Lipton SA. Prevention of classic migraine headache by digital massage of the superficial temporal arteries during visual aura. Ann Neurol. 1986;19:515–6.PubMedCrossRef
73.
74.
Hmaidan Y, Cianchetti C. Effectiveness of a prolonged compression of scalp arteries on migraine attacks. J Neurol. 2006;253:811–12.PubMedCrossRef
75.
• Cianchetti C. The role of neurovascular scalp structures in migraine. Cephalalgia. 2012;32:778–84. A review suggesting the role of scalp neurovascular structures in the production of migraine pain in at least part of the migraine patient population. PubMedCrossRef
76.
Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–7.PubMedCrossRef
77.
Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 2013;12:454–61.PubMedCrossRef
78.
Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008;28:226–36.PubMedCrossRef
79.
Dodick DW. Examining the essence of migraine – is it the blood vessel or the brain? A debate Headache. 2008;48:661–7.CrossRef
80.
Hansen JM, Sitarz J, Birk S, et al. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia. 2006;26:992–1003.PubMedCrossRef
81.
Amin FM, Asghar MS, Ravneberg JW, et al. The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers. Cephalalgia. 2013 Apr 15 [Epub ahead of print].
82.
Tissot, S-A, Traité des nerfs et de leurs maladies, 1778, IX p.90–173. A Lausanne: Chex François Grasset & Comp.
83.
Ellis GL, Delaney J, DeHart DA, et al. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993;22:191–5.PubMedCrossRef
84.
Derry S, Moore RA, McQuay HJ. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headache in adults. Cochrane Database Syst Rev. 2010;11, CD008040.PubMed
85.
Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2012;2, CD008783.PubMed
86.
Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without antiemetic for acute migraine headache in adults. Cochrane Database Syst Rev. 2010;10, CD008039.PubMed
87.
Yin J, Abell TD, McCallum RW, et al. Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation. 2012;15:224–31.PubMedCrossRef
88.
Abell TL, Johnson WD, Kedar A, Runnels JM, Thompson J, Weeks ES, et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc. 2011;74:496–503.PubMedCrossRef
Metadata
Title
Why Does Vomiting Stop a Migraine Attack?
Authors
Nu Cindy Chai
Robert E. Shapiro
Alan M. Rapoport
Publication date
01-09-2013
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 9/2013
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-013-0362-7

Other articles of this Issue 9/2013

Current Pain and Headache Reports 9/2013 Go to the issue

Neuropathic Pain (E Eisenberg, Section Editor)

Update on Neuropathic Pain Treatment: Ion Channel Blockers and Gabapentinoids

Neuropathic Pain (E Eisenberg, Section Editor)

Review of Neuropathic Pain Screening and Assessment Tools

Myofascial Pain (R Gerwin, Section Editor)

Myofascial Trigger Point Therapy: Laser Therapy and Dry Needling

Secondary Headache (K Henry, Section Editor)

Migraine and Neurogenetic Disorders

Fibromyalgia (M Peres, Section Editor)

Fibromyalgia Comorbid with Anxiety Disorders and Depression: Combined Medical and Psychological Treatment

Neuropathic Pain (E Eisenberg, Section Editor)

Conditioned Pain Modulation: A Predictor for Development and Treatment of Neuropathic Pain